Grant: Engage Plus Grants Program
University of Guelph
$12,500.00
Development of a molecular assay for determining the number and viability of live vaccine organisms
FY 2013-14
Summary
The proposed research will investigate the possibility of combining so-called 'viability PCR' with multiplexed next generation sequencing using an Illumina? NGS platform to determine both the number of oocysts of each of several species in a mixture as well as the viability of these enumerated oocysts. Briefly, standardized methods of DNA extraction and qPCR of a short region of the mitochondrial COI gene of Eimeria species found in live coccidiosis vaccines will be developed. Viability will be assessed using the intercalating dye propidium monoazide (PMA) that photoreacts with DNA irreversibly, preventing PCR amplification from 'non-viable' oocysts. Multiplexed next generation sequencing (Illumina) of PCR products will be used toprovide sequence data from mixed template PCR products that will permit species identification and enumeration in mixed samples. Combining PMA viability qPCR with downstream Illumina sequencing of the PCR product to give numbers, species and viability of any and all Eimeria spp. found in a particular sample should be possible at reasonable cost. Such an innovation would greatly assist the formulation and marketing of live coccidiosis vaccines both nationally and globally, and will enhance the market position of Ceva Vetech in this competitive field.
Program
Engage Plus Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
461263-2013
Name nom
Barta, John
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
1
Application title
Development of a molecular assay for determining the number and viability of live vaccine organisms
Keyword
NSERC
Application summary
The proposed research will investigate the possibility of combining so-called 'viability PCR' with multiplexed next generation sequencing using an Illumina? NGS platform to determine both the number of oocysts of each of several species in a mixture as well as the viability of these enumerated oocysts. Briefly, standardized methods of DNA extraction and qPCR of a short region of the mitochondrial COI gene of Eimeria species found in live coccidiosis vaccines will be developed. Viability will be assessed using the intercalating dye propidium monoazide (PMA) that photoreacts with DNA irreversibly, preventing PCR amplification from 'non-viable' oocysts. Multiplexed next generation sequencing (Illumina) of PCR products will be used toprovide sequence data from mixed template PCR products that will permit species identification and enumeration in mixed samples. Combining PMA viability qPCR with downstream Illumina sequencing of the PCR product to give numbers, species and viability of any and all Eimeria spp. found in a particular sample should be possible at reasonable cost. Such an innovation would greatly assist the formulation and marketing of live coccidiosis vaccines both nationally and globally, and will enhance the market position of Ceva Vetech in this competitive field.